These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 313269)

  • 21. Induction of lymphocyte-mediated cytotoxicity against allogeneic tumor cells by concanavalin A in vivo.
    Anaclerio A; Waterfield JD; Möller G
    J Immunol; 1974 Sep; 113(3):870-5. PubMed ID: 4413847
    [No Abstract]   [Full Text] [Related]  

  • 22. Inhibition of cytotoxic T lymphocyte activity by concanavalin A.
    Sitkovsky MV; Pasternack MS; Eisen HN
    J Immunol; 1982 Oct; 129(4):1372-6. PubMed ID: 6980931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphocyte-target cell conjugation: membrane receptors for alloantigens.
    Berke G
    Adv Exp Med Biol; 1976; 66():483-7. PubMed ID: 1083650
    [No Abstract]   [Full Text] [Related]  

  • 24. Blastogenesis & DNA synthesis in concanavalin A--driven regeneration of cytotoxic response in memory T cells.
    Chakravarty AK
    Indian J Exp Biol; 1978 Feb; 16(2):148-52. PubMed ID: 308043
    [No Abstract]   [Full Text] [Related]  

  • 25. Inhibition by sera and soluble antigens of T-cell-mediated cytotoxicity against leukaemia-associated antigens.
    Ting CC; Rogers MJ
    Nature; 1977 Apr; 266(5604):727-9. PubMed ID: 301609
    [No Abstract]   [Full Text] [Related]  

  • 26. Early steps in specific tumor cell lysis by sensitized mouse T lymphocytes. IV. Inhibition of programming for lysis by pharmacologic agents.
    Gately MK; Wechter WJ; Martz E
    J Immunol; 1980 Aug; 125(2):783-92. PubMed ID: 6248595
    [No Abstract]   [Full Text] [Related]  

  • 27. Membrane defects in the tolerant B cell. II. Mechanism of capping failure and reversal by antigen exposure.
    Ashman RF
    Cell Immunol; 1979 May; 44(2):329-42. PubMed ID: 313266
    [No Abstract]   [Full Text] [Related]  

  • 28. Capping of exogenous Forssman glycolipid on cells.
    Stern PL; Bretscher MS
    J Cell Biol; 1979 Sep; 82(3):829-33. PubMed ID: 389939
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of T cell effector function by concanavalin A.
    Miltenberg AM; Meijer-Paape ME; Daha MR; Paul LC
    Transplant Proc; 1988 Apr; 20(2):293. PubMed ID: 3259033
    [No Abstract]   [Full Text] [Related]  

  • 30. Capping of human T cell specific determinants: kinetics of capping and receptor re-expression and regulation by the cytoskeleton.
    Kammer GM; Smith JA; Mitchell R
    J Immunol; 1983 Jan; 130(1):38-44. PubMed ID: 6600189
    [No Abstract]   [Full Text] [Related]  

  • 31. Selective cell surface expression of thymus leukemia antigen during S phase of the cell cycle.
    Williams JL; Pickering JW; Wolcott M
    J Immunol; 1979 Mar; 122(3):1121-5. PubMed ID: 312816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. H-2-restricted cytolytic T lymphocytes specific for a subclass of AKR endogenous leukemia virus-induced tumors: correlation of tumor cell susceptibility with expression of the gross cell surface antigen.
    Green WR
    J Immunol; 1980 Dec; 125(6):2584-90. PubMed ID: 6159413
    [No Abstract]   [Full Text] [Related]  

  • 33. Detection and characterization of human leukemia-associated antigens on leukemic cell lines and thymocytes. II. Isolation of human thymus-leukemia-associated antigens from the cell surface and partial characterization.
    Seon BK; Yoshizaki K; Pressman D
    J Immunol; 1979 May; 122(5):1951-9. PubMed ID: 312855
    [No Abstract]   [Full Text] [Related]  

  • 34. A study of the inability of subcellular fractions to elicit primary anti-H-2 cytotoxic T lymphocytes.
    Hale AH; McGee MP
    Cell Immunol; 1981 Mar; 58(2):277-85. PubMed ID: 6971170
    [No Abstract]   [Full Text] [Related]  

  • 35. Functional properties of T and B lymphocytes in cell-mediated immunity.
    Petrányl GG
    Haematologia (Budap); 1974; 8(1-4):361-82. PubMed ID: 4142621
    [No Abstract]   [Full Text] [Related]  

  • 36. Relationship between membrane fluidity and capping of receptors for concanavalin A.
    Mak WW; Wong JT
    Can J Biochem; 1980 Dec; 58(12):1421-9. PubMed ID: 6265046
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macrophage-mediated in vitro sensitization of T-lymphocytes. I; Detection of murine leukemia virus-associated antigens.
    Treves AJ; Feldman M; Kaplan HS
    J Natl Cancer Inst; 1977 May; 58(5):1527-9. PubMed ID: 192905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phenethyl isothiocyanate promotes immune responses in normal BALB/c mice, inhibits murine leukemia WEHI-3 cells, and stimulates immunomodulations in vivo.
    Tsou MF; Tien N; Lu CC; Chiang JH; Yang JS; Lin JP; Fan MJ; Lu JJ; Yeh SP; Chung JG
    Environ Toxicol; 2013 Mar; 28(3):127-36. PubMed ID: 21626647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of hexachlorocyclohexane isomers on concanavalin A 'capping' in bovine lymphocytes.
    Kwong CH; Mueller GC
    Biochim Biophys Acta; 1979 Sep; 586(3):501-11. PubMed ID: 89870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Permanent inhibition of capping of spleen lymphocytes from neonatally oestrogen-treated female mice.
    Kalland T; Forsberg JG
    Immunology; 1980 Feb; 39(2):281-4. PubMed ID: 7380472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.